Germany’s Dermapharm Holding SE said strong demand for dietary supplements helped to push up group sales by almost a fifth in 2021.
The Grünwald-based firm reported turnover up by 18.8% to €943m ($1.03bn) for the 12 months as sales jumped by 35
EU Business News: Dermapharm Gets Boost From Vitamin D; Sanofi Plans Turkish Launch; Krka Posts Sales RIse
A round-up of European consumer health business news: Dermapharm sees 2021 sales rise on the back of increased vitamin D demand; Sanofi plans to launch Enzymatica's ColdZyme in Turkey; and Slovenia's Krka posts rise in OTC sales.
